Literature DB >> 18396002

A case of galactosialidosis with a homozygous Q49R point mutation.

Naoko Matsumoto1, Kenjiro Gondo, Johji Kukita, Katsumi Higaki, Rubigilda C Paragison, Eiji Nanba.   

Abstract

Galactosialidosis is a rare lysosomal storage disease caused by a combined deficiency of lysosomal beta-galactosidase and neuraminidase, due to a primary defect in protective protein/cathepsin A. Three subtypes are recognized: the early infantile type, the late infantile type, and the juvenile/adult type. Here, we report a case of early infantile galactosialidosis in a female who was born at 31 weeks of gestation, after detection of fetal ascites at 21 weeks of gestation and development of fetal hydrops. After birth she received intensive treatment that led to improvement of edema and pleural effusion, but ascites slowly developed. She died of renal failure on day 207. An autopsy showed that all organs contained vacuolated cells, compatible with a storage disease. The patient had decreased activity of beta-galactosidase and undetectable neuraminidase activity in fibroblasts. A single A-G base transition at position 146 of exon 1 (Q49R) in protective protein/cathepsin A gene was found. The mutation has been reported previously in a Japanese patient with different phenotypes. However homozygous Q49R mutation detected in our case was severe prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396002     DOI: 10.1016/j.braindev.2008.01.012

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Metab Brain Dis       Date:  2017-05-30       Impact factor: 3.584

Review 2.  Galactosialidosis: review and analysis of CTSA gene mutations.

Authors:  Anna Caciotti; Serena Catarzi; Rodolfo Tonin; Licia Lugli; Carmen Rodriguez Perez; Helen Michelakakis; Irene Mavridou; Maria Alice Donati; Renzo Guerrini; Alessandra d'Azzo; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-08-02       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.